Abstract: A computer-implemented method, system, and non-transitory computer-readable medium may provide event attendees of a network-accessible calendar with a way to generate collaborative notes for a meeting related to an event. In some embodiments, a calendar entry in a network-accessible calendar may be identified. The calendar entry may correspond to an event and may identify the event attendees. A collaborative document that capable of receiving modifications to the event from the event attendees may be created. The event attendees may further be provided access to the collaborative document.

Abstract: A computer-implemented method, system, and non-transitory computer-readable medium may provide event attendees of a network-accessible calendar with a way to generate collaborative notes for a meeting related to an event. In some embodiments, a calendar entry in a network-accessible calendar may be identified. The calendar entry may correspond to an event and may identify the event attendees. A collaborative document that capable of receiving modifications to the event from the event attendees may be created. The event attendees may further be provided access to the collaborative document.

Abstract: A vehicle tyre data monitoring system has a wheel mounted sensor means that is adapted to transmit one or more of pressure, temperature, angular velocity, and force vector data for a tyre as a digital serial datagram through a two-wire communication channel to a chassis mounted reader means. The communication channel is adapted to simultaneously supply power to the sensor means and receive the data for processing and subsequent display to a user of the system.

Abstract: Human PPP1R5 polypeptides and DNA (RNA) encoding such PPP1R5 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such PPP1R5, or compounds which inhibit or stimulate PPP1R5 for dysfunctions or diseases which involve resistance to the action of insulin on glycogen synthesis are also disclosed. Agonist and antagonists of these PPP1R5 proteins and methods of their use are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the PPP1R5 and for detecting altered levels of the polypeptide in a host.

Abstract: Human PPP1R5 polypeptides and DNA (RNA) encoding such PPP1R5 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such PPP1R5, or compounds which inhibit or stimulate PPP1R5 for dysfunctions or diseases which involve resistance to the action of insulin on glycogen synthesis are also disclosed. Agonist and antagonists of these PPP1R5 proteins and methods of their use are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the PPP1R5 and for detecting altered levels of the polypeptide in a host.